Research Article

Evaluation of HLA-G 14 bp Ins/Del and +3142G>C Polymorphism with Susceptibility and Early Disease Activity in Rheumatoid Arthritis

Table 1

Association of HLA-G polymorphisms and the risk of RA.

HLA-G polymorphismsCase
(%)
Control
(%)
OR (95% CI)

14-bp ins/del (rs66554220)
Codominant
 Ins/ins36 (18.6)34 (21.5)1.00
 Ins/del123 (63.4)97 (61.4)1.20 (0.70–2.05)0.5821.00
 Del/del35 (18.0)27 (17.1)1.22 (0.62–2.43)0.6031.00

Dominant
 Ins/ins36 (18.6)34 (21.5)1.00
 Ins/del + del/del158 (81.4)124 (78.5)1.20 (0.71–2.03)0.5051.00

Recessive
 Ins/ins + ins/del159 (82.0)131 (82.9)1.00
 Del/del35 (18.0)27 (17.1)1.07 (0.61–1.86)0.8881.00

Allele
 Ins195 (50.3)165 (52.2)1.00
 Del193 (49.7)151 (47.8)1.08 (0.80–1.46)0.6491.00

+3142G>C (rs1063320)
Codominant
 GG135 (69.6)89 (56.3)1.00
 GC52 (26.8)56 (35.4)0.61 (0.38–0.97)0.0380.076
 CC7 (3.6)13 (8.2)0.36 (0.14–0.92)0.0340.068

Dominant
 GG135 (69.6)89 (56.3)1.00
 GC + CC59 (30.4)69 (43.7)0.56 (0.36–0.87)0.0110.022

Recessive
 GG + GC187 (96.4)145 (91.8)1.00
 CC7 (3.6)13 (8.2)0.42 (0.16–1.07)0.0681.00

Allele
 G322 (83.0)234 (74.0)1.00
 C66 (17.0)82 (26.0)0.58 (0.41–0.84)0.0040.005

: Bonferroni-corrected .